Gilead to buy Ouro Medicines for up to $2.2 billion [Yahoo! Finance]
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research [Yahoo! Finance]
Arcellx (ACLX) was upgraded by Truist Financial Corporation from "hold" to "strong-buy".
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—QETA, NIMU, ACLX, and FONR
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal [Yahoo! Finance]